PL1499278T3 - Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon - Google Patents

Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon

Info

Publication number
PL1499278T3
PL1499278T3 PL04737220T PL04737220T PL1499278T3 PL 1499278 T3 PL1499278 T3 PL 1499278T3 PL 04737220 T PL04737220 T PL 04737220T PL 04737220 T PL04737220 T PL 04737220T PL 1499278 T3 PL1499278 T3 PL 1499278T3
Authority
PL
Poland
Prior art keywords
dosage form
immediate
pharmaceutical dosage
release pharmaceutical
polymorphous tibolone
Prior art date
Application number
PL04737220T
Other languages
English (en)
Inventor
Haan Pieter N V Organon De
Original Assignee
Msd Oss Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33442854&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1499278(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Msd Oss Bv filed Critical Msd Oss Bv
Publication of PL1499278T3 publication Critical patent/PL1499278T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL04737220T 2003-05-23 2004-05-19 Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon PL1499278T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03101500 2003-05-23
PCT/EP2004/050852 WO2004103378A1 (en) 2003-05-23 2004-05-19 Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
EP04737220A EP1499278B1 (en) 2003-05-23 2004-05-19 Immediate-release pharmaceutical dosage form comprising polymorphous tibolone

Publications (1)

Publication Number Publication Date
PL1499278T3 true PL1499278T3 (pl) 2005-09-30

Family

ID=33442854

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04737220T PL1499278T3 (pl) 2003-05-23 2004-05-19 Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon

Country Status (16)

Country Link
US (1) US20060134191A1 (pl)
EP (1) EP1499278B1 (pl)
JP (1) JP2006514996A (pl)
KR (2) KR20060028822A (pl)
AT (1) ATE296606T1 (pl)
AU (1) AU2004203420B8 (pl)
CA (1) CA2473718A1 (pl)
DE (1) DE602004000016T2 (pl)
DK (1) DK1499278T3 (pl)
ES (1) ES2243919T3 (pl)
MX (1) MXPA05000824A (pl)
NZ (1) NZ534446A (pl)
PL (1) PL1499278T3 (pl)
PT (1) PT1499278E (pl)
WO (1) WO2004103378A1 (pl)
ZA (1) ZA200406042B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE344020T1 (de) * 2004-02-06 2006-11-15 Helm Ag Pharmazeutische zubereitungen mit amorphem tibolon
WO2009055030A2 (en) * 2007-10-25 2009-04-30 Nektar Therapeutics Powder conditioning of unit dose drug packages
KR101361244B1 (ko) * 2012-02-23 2014-02-11 박현석 무선 메시지를 이용한 문서 전송 시스템 및 방법
US10139090B2 (en) * 2015-11-02 2018-11-27 Joseph Goodrich Rechargeable illuminating shoes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665514A (pl) * 1964-06-16
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
IL123984A (en) * 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
EP1251855A1 (en) * 2000-01-28 2002-10-30 Endorecherche, Inc. Selective estrogen receptor modulators in combination with estrogens
WO2003032924A2 (en) * 2001-10-18 2003-04-24 Ivax Corporation Novel tibolone formulations

Also Published As

Publication number Publication date
DE602004000016T2 (de) 2005-11-03
DE602004000016D1 (de) 2005-07-07
AU2004203420B2 (en) 2008-01-31
US20060134191A1 (en) 2006-06-22
KR20050038590A (ko) 2005-04-27
EP1499278B1 (en) 2005-06-01
PT1499278E (pt) 2005-08-31
AU2004203420A1 (en) 2004-12-02
AU2004203420B8 (en) 2008-02-21
DK1499278T3 (da) 2005-10-03
NZ534446A (en) 2007-03-30
MXPA05000824A (es) 2005-04-28
WO2004103378A1 (en) 2004-12-02
ES2243919T3 (es) 2005-12-01
ZA200406042B (en) 2006-05-31
KR20060028822A (ko) 2006-04-03
ATE296606T1 (de) 2005-06-15
CA2473718A1 (en) 2004-11-23
JP2006514996A (ja) 2006-05-18
EP1499278A1 (en) 2005-01-26

Similar Documents

Publication Publication Date Title
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
MX2007015480A (es) Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
GEP20074047B (en) Pramipexole once-daily dosage form
DK0954314T3 (da) Doseringsformer til bedring af mandlig erektionsdefekt
TW200505498A (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
NO20060445L (no) Fast farmasoytisk preparat omfattende amisulprid
BG108516A (en) Pharmaceutical formulation
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
IL165786A0 (en) Ibuprofen suspension
ATE287264T1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
MXPA03008420A (es) Forma farmaceutica solida oralmente dispersa.
ZA200506992B (en) Fibrate tablet and method for the production thereof
PL1499278T3 (pl) Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
GB0001315D0 (en) Organic compounds
DE60211916D1 (de) Synergistische füllzusammensetzung
MY141008A (en) Oral formulations of deoxypeganine and their uses
TW200621304A (en) Pharmaceutical composition
TW200621224A (en) Pharmaceutical composition
WO2007119249A3 (en) Pharmaceutical compositions of cefixime
WO2005115092A3 (en) Micronized oral pharmaceutical composition
IL162769A0 (en) Tibolone in the treatment of complaints associatedwith the administration of drugs which prevent thesynthesis of endogenousestrogen
ECSP982396A (es) Composiciones que contienen tetrahidrolipstatina
HU0101360D0 (en) Process for the preparation of easily compressible tablets from pharmaceutically active agents with poor tablet formulation characteristics